Evol Science ^Companies

Evol Science is a biotechnology company that focuses on identifying and exploiting mechanisms of cancer cell resistance. They use their proteo-genomic system and AI-driven data analytic platform to discover and target drug resistance in cancer cells, accelerating drug development and clinical translation. Evol Science has generated multiple novel drug combinations to treat late-stage, RAS-driven cancers, including metastatic melanoma, pancreatic, colorectal, breast, and lung. They are currently preparing for proof-of-principle clinical trials for their first combination in the first half of 2019. Their ultimate goal is to make the deadliest cancers survivable.